Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00290901
Collaborator
(none)
754
54
14
Study Details
Study Description
Brief Summary
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Six Week Double-Blind, Randomized, Multicenter Comparison Study of the Analgesic Effectiveness of Celecoxib 200 mg BID Compared to Tramadol Hydrochloride 50 mg QID in Subjects With Chronic Low Back Pain
Study Start Date
:
Mar 1, 2006
Actual Primary Completion Date
:
Dec 1, 2006
Outcome Measures
Primary Outcome Measures
- To compare the analgesic effectiveness of celecoxib and tramadol in subjects with Chronic Low Back Pain measured by the Numerical Rating Scale (NRS-Pain) at Week 6. []
Secondary Outcome Measures
- To compare the effects of treatment with celecoxib 200 mg BID and tramadol hydrochloride 50 mg QID on improvement in functionality and quality of life in subjects with chronic low back pain. []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- The subject presents with duration of chronic low back pain of > 3 months requiring regular use of analgesics (> 4 days/week), except for acetaminophen which cannot have been the sole analgesic used.
Exclusion Criteria:
- The subject has chronic low back pain, which is neurologic in etiology (i.e., radiculopathy, neuropathy, myelopathy)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pfizer Investigational Site | Phoenix | Arizona | United States | |
2 | Pfizer Investigational Site | Scottsdale | Arizona | United States | |
3 | Pfizer Investigational Site | Tucson | Arizona | United States | |
4 | Pfizer Investigational Site | Little Rock | Arkansas | United States | |
5 | Pfizer Investigational Site | Anaheim | California | United States | |
6 | Pfizer Investigational Site | La Mesa | California | United States | |
7 | Pfizer Investigational Site | Long Beach | California | United States | |
8 | Pfizer Investigational Site | Oceanside | California | United States | |
9 | Pfizer Investigational Site | Paramount | California | United States | |
10 | Pfizer Investigational Site | Sacramento | California | United States | |
11 | Pfizer Investigational Site | San Francisco | California | United States | |
12 | Pfizer Investigational Site | San Luis Obispo | California | United States | |
13 | Pfizer Investigational Site | Tustin | California | United States | |
14 | Pfizer Investigational Site | Vista | California | United States | |
15 | Pfizer Investigational Site | Boulder | Colorado | United States | |
16 | Pfizer Investigational Site | Colorado Springs | Colorado | United States | |
17 | Pfizer Investigational Site | Denver | Colorado | United States | |
18 | Pfizer Investigational Site | Cos Cob | Connecticut | United States | |
19 | Pfizer Investigational Site | Washington | District of Columbia | United States | |
20 | Pfizer Investigational Site | Miami | Florida | United States | |
21 | Pfizer Investigational Site | Pembroke Pines | Florida | United States | |
22 | Pfizer Investigational Site | West Palm Beach | Florida | United States | |
23 | Pfizer Investigational Site | Decatur | Georgia | United States | |
24 | Pfizer Investigational Site | Woodstock | Georgia | United States | |
25 | Pfizer Investigational Site | Libertyville | Illinois | United States | |
26 | Pfizer Investigational Site | Morton Grove | Illinois | United States | |
27 | Pfizer Investigational Site | Arkansas City | Kansas | United States | |
28 | Pfizer Investigational Site | Overland Park | Kansas | United States | |
29 | Pfizer Investigational Site | Wichita | Kansas | United States | |
30 | Pfizer Investigational Site | Madisonville | Kentucky | United States | |
31 | Pfizer Investigational Site | Baltimore | Maryland | United States | |
32 | Pfizer Investigational Site | Wheaton | Maryland | United States | |
33 | Pfizer Investigational Site | Jackson | Mississippi | United States | |
34 | Pfizer Investigational Site | Kansas City | Missouri | United States | |
35 | Pfizer Investigational Site | Saint Louis | Missouri | United States | |
36 | Pfizer Investigational Site | Omaha | Nebraska | United States | |
37 | Pfizer Investigational Site | Brooklyn | New York | United States | |
38 | Pfizer Investigational Site | New York | New York | United States | |
39 | Pfizer Investigational Site | Rochester | New York | United States | |
40 | Pfizer Investigational Site | Raleigh | North Carolina | United States | |
41 | Pfizer Investigational Site | Medford | Oregon | United States | |
42 | Pfizer Investigational Site | Portland | Oregon | United States | |
43 | Pfizer Investigational Site | Camp Hill | Pennsylvania | United States | |
44 | Pfizer Investigational Site | Duncansville | Pennsylvania | United States | |
45 | Pfizer Investigational Site | Charleston | South Carolina | United States | |
46 | Pfizer Investigational Site | Columbia | South Carolina | United States | |
47 | Pfizer Investigational Site | Johnson City | Tennessee | United States | |
48 | Pfizer Investigational Site | New Tazewell | Tennessee | United States | |
49 | Pfizer Investigational Site | Austin | Texas | United States | |
50 | Pfizer Investigational Site | San Angelo | Texas | United States | |
51 | Pfizer Investigational Site | San Antonio | Texas | United States | |
52 | Pfizer Investigational Site | Arlington | Virginia | United States | |
53 | Pfizer Investigational Site | Danville | Virginia | United States | |
54 | Pfizer Investigational Site | Rio Piedras | Puerto Rico |
Sponsors and Collaborators
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Investigators
- Study Director: Pfizer CT.gov Call Center, Pfizer
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
ClinicalTrials.gov Identifier:
NCT00290901
Other Study ID Numbers:
- A3191165
First Posted:
Feb 13, 2006
Last Update Posted:
Mar 3, 2021
Last Verified:
Mar 1, 2021